Antibiotic prophylaxis in primary and revision shoulder replacement: a systematic review.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
11 May 2020
Historique:
received: 09 04 2020
accepted: 06 05 2020
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 2 2 2021
Statut: epublish

Résumé

One of the most common bacteria responsible for most Periprosthetic joint infection (PJI) is Propionibacterium acnes. Even though the rate of infections in patients undergoing total shoulder arthroplasty is increasing, effective diagnostic tests and the precautions taken during the surgery are not yet adequate. This systematic review aims to evaluate the effectiveness of antimicrobial prophylaxis in PJI in shoulder replacement and to provide health workers with the best approach to the use of antimicrobial agents based on currently available clinical evidence. a systematic review of the literature was carried out in accordance with the PRISMA Statement. Studies concerning the effectiveness of antimicrobial prophylaxis in the prevention of PJI in patients undergoing shoulder replacement were included. Seven studies were included in the final analysis because they were considered valid. A total of 3272 patients underwent a surgical procedure, most of which were males. The male population has a greater presence of hair, therefore a greater risk of P. acnes. in surface cultures. Patients were assessed at an average follow-up period of 20 months ranging from 9 weeks to 53 months. The optimal perioperative antimicrobial regimen is controversial. The clinical guidelines recommend the use of only one antibiotic as prophylaxis but considering the increase in the rates of antibiotic-resistant infections, the question arises whether antibiotic prophylaxis should be extended for adequate coverage. Shoulder arthroplasty performed on the male population must be carefully checked after surgery for the possible presence of P. Acnes.

Sections du résumé

BACKGROUND BACKGROUND
One of the most common bacteria responsible for most Periprosthetic joint infection (PJI) is Propionibacterium acnes. Even though the rate of infections in patients undergoing total shoulder arthroplasty is increasing, effective diagnostic tests and the precautions taken during the surgery are not yet adequate. This systematic review aims to evaluate the effectiveness of antimicrobial prophylaxis in PJI in shoulder replacement and to provide health workers with the best approach to the use of antimicrobial agents based on currently available clinical evidence.
METHODS METHODS
a systematic review of the literature was carried out in accordance with the PRISMA Statement. Studies concerning the effectiveness of antimicrobial prophylaxis in the prevention of PJI in patients undergoing shoulder replacement were included.
RESULTS RESULTS
Seven studies were included in the final analysis because they were considered valid. A total of 3272 patients underwent a surgical procedure, most of which were males. The male population has a greater presence of hair, therefore a greater risk of P. acnes. in surface cultures. Patients were assessed at an average follow-up period of 20 months ranging from 9 weeks to 53 months.
CONCLUSION CONCLUSIONS
The optimal perioperative antimicrobial regimen is controversial. The clinical guidelines recommend the use of only one antibiotic as prophylaxis but considering the increase in the rates of antibiotic-resistant infections, the question arises whether antibiotic prophylaxis should be extended for adequate coverage. Shoulder arthroplasty performed on the male population must be carefully checked after surgery for the possible presence of P. Acnes.

Identifiants

pubmed: 32393217
doi: 10.1186/s12891-020-03332-z
pii: 10.1186/s12891-020-03332-z
pmc: PMC7216509
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

292

Références

Musculoskelet Surg. 2017 Aug;101(2):105-112
pubmed: 28444541
J Bone Joint Surg Am. 2018 Jun 6;100(11):958-964
pubmed: 29870447
Surg Infect (Larchmt). 2013 Feb;14(1):73-156
pubmed: 23461695
J Am Acad Orthop Surg. 2011 Apr;19(4):208-18
pubmed: 21464214
J Bone Joint Surg Am. 2009 Aug;91(8):1949-53
pubmed: 19651954
J Shoulder Elbow Surg. 2018 Jul;27(7):1333-1341
pubmed: 29444755
Lancet Infect Dis. 2016 Dec;16(12):e288-e303
pubmed: 27816414
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Eur J Clin Microbiol Infect Dis. 2005 Nov;24(11):739-44
pubmed: 16328558
Joints. 2017 Feb 07;4(4):236-246
pubmed: 28217660
Clin Infect Dis. 2018 Jan 18;66(3):329-336
pubmed: 29361015
Surg Infect (Larchmt). 2014 Aug;15(4):412-6
pubmed: 24824510
Antimicrob Agents Chemother. 2013 Jul;57(7):3424-6
pubmed: 23629711
Musculoskelet Surg. 2016 Aug;100(2):83-91
pubmed: 27316439
J Infect. 2015 Nov;71(5):518-25
pubmed: 26283328
Orthop Clin North Am. 2018 Apr;49(2):241-256
pubmed: 29499825
Diagn Microbiol Infect Dis. 2016 Dec;86(4):442-445
pubmed: 27745737
PLoS Med. 2017 Jul 10;14(7):e1002340
pubmed: 28692690
Shoulder Elbow. 2019 Jun;11(3):167-181
pubmed: 31210788
Sports Med Arthrosc Rev. 2011 Dec;19(4):366-79
pubmed: 22089287
J Shoulder Elbow Surg. 2015 Apr;24(4):578-86
pubmed: 25440514
HSS J. 2017 Jul;13(2):159-164
pubmed: 28690466
J Orthop. 2018 Feb 02;15(1):177-180
pubmed: 29657463
Pediatr Rev. 2002 Apr;23(4):149-50
pubmed: 11927749
J Bone Joint Surg Am. 2016 Apr 6;98(7):597-606
pubmed: 27053589
Clin Orthop Relat Res. 2019 Jul;477(7):1712-1718
pubmed: 30998585
Clin Microbiol Infect. 2005 Mar;11(3):204-13
pubmed: 15715718
J Shoulder Elbow Surg. 2015 Jun;24(6):844-7
pubmed: 25547858
JAMA Surg. 2017 Aug 1;152(8):784-791
pubmed: 28467526
J Shoulder Elbow Surg. 2016 May;25(5):846-52
pubmed: 26704361

Auteurs

Umile Giuseppe Longo (UG)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University, Via Alvaro del Portillo, 200, 00128 Trigoria, Rome, Italy. g.longo@unicampus.it.

Vincenzo Candela (V)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University, Via Alvaro del Portillo, 200, 00128 Trigoria, Rome, Italy.

Gabriella Facchinetti (G)

Research Unit Nursing Science, Campus Bio-Medico di Roma University, Rome, Italy.

Anna Marchetti (A)

Research Unit Nursing Science, Campus Bio-Medico di Roma University, Rome, Italy.

Silvia Dsoke (S)

Research Unit Nursing Science, Campus Bio-Medico di Roma University, Rome, Italy.

Claudia Mazzella (C)

Research Unit Nursing Science, Campus Bio-Medico di Roma University, Rome, Italy.

Laura Risi Ambrogioni (L)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University, Via Alvaro del Portillo, 200, 00128 Trigoria, Rome, Italy.

Maria Grazia De Marinis (MG)

Research Unit Nursing Science, Campus Bio-Medico di Roma University, Rome, Italy.

Vincenzo Denaro (V)

Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University, Via Alvaro del Portillo, 200, 00128 Trigoria, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH